Position in MRK
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$7,544,620
+$545,186 QoQ
Shares Held
58,713
+0.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#852
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Texas Yale Capital Corp. holds $42,723,383 across 10 Drug Manufacturers - General names. MRK ranks #3 (17.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
47,632 | $11,986,116 | |
| 2 | JNJ |
Johnson & Johnson
|
36,037 | $9,152,316 | |
| 3 | MRK |
Merck & Co., Inc.
This page
|
58,713 | $7,544,620 | |
| 4 | LLY |
ELI LILLY & Co
|
5,751 | $6,897,922 | |
| 5 | AMGN |
Amgen Inc
|
10,322 | $3,737,802 | |
| 6 | NVO |
Novo Nordisk A S
|
22,899 | $1,097,778 | |
| 7 | BIIB |
Biogen Inc.
|
3,987 | $861,431 | |
| 8 | NVS |
Novartis AG
|
4,542 | $711,822 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,544,620 | 58,713 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $6,999,434 | 58,188 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $6,084,870 | 57,808 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $4,824,548 | 57,483 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $2,998,818 | 37,883 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $3,325,428 | 37,048 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $4,047,642 | 40,688 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $4,535,359 | 39,938 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $4,998,177 | 40,373 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $5,265,860 | 39,908 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $4,350,770 | 39,908 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $4,108,528 | 39,908 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $4,628,062 | 40,108 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $4,267,090 | 40,108 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $4,449,982 | 40,108 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,652,176 | 42,408 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $3,771,976 | 41,373 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $3,327,373 | 40,553 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $3,107,981 | 40,553 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,990,204 | 39,811 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $3,094,546 | 39,791 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $3,041,202 | 39,450 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $3,791,428 | 46,350 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $3,841,416 | 46,310 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $3,581,153 | 46,310 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $3,600,559 | 46,797 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||